Satyavrat Shukla

2022

In 2022, Satyavrat Shukla earned a total compensation of $1.7M as President and Chief Executive Officer and Former Chief Financial Officer and Treasurer at Spero Therapeutics, a 25% decrease compared to previous year.

Compensation breakdown

Bonus$168,000
Non-Equity Incentive Plan$172,800
Option Awards$424,807
Salary$478,333
Stock Awards$424,997
Other$4,133
Total$1,673,070

Shukla received $478.3K in salary, accounting for 29% of the total pay in 2022.

Shukla also received $168K in bonus, $172.8K in non-equity incentive plan, $424.8K in option awards, $425K in stock awards and $4.1K in other compensation.

Rankings

In 2022, Satyavrat Shukla's compensation ranked 2,034th out of 5,694 executives tracked by ExecPay. In other words, Shukla earned more than 64.3% of executives.

ClassificationRankingPercentile
All
2,034
out of 5,694
64th
Division
Manufacturing
1,089
out of 3,099
65th
Major group
Chemicals And Allied Products
466
out of 1,406
67th
Industry group
Drugs
427
out of 1,307
67th
Industry
Pharmaceutical Preparations
310
out of 953
68th
Source: SEC filing on September 1, 2023.

Shukla's colleagues

We found two more compensation records of executives who worked with Satyavrat Shukla at Spero Therapeutics in 2022.

2022

Ankit Mahadevia

Spero Therapeutics

Chief Executive Officer

2022

Tamara Joseph

Spero Therapeutics

Chief Legal Officer

News

You may also like